Aldeyra Therapeutics, Inc.
35
1
1
33
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 5/100
2.9%
1 terminated/withdrawn out of 35 trials
97.1%
+10.6% vs industry average
37%
13 trials in Phase 3/4
82%
27 of 33 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (35)
A Study in Subjects With Retinitis Pigmentosa
Role: lead
A Clinical Trial Evaluating Patients With Primary Vitreoretinal Lymphoma
Role: lead
A Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease
Role: lead
A Clinical Trial Investigating the Safety and Efficacy of Subjects With Alcohol Associated Hepatitis (Part 1)
Role: lead
A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Clinical Trial Evaluating the Safety of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease
Role: lead
A Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease
Role: lead
The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy
Role: lead
A Clinical Trial to Assess the Efficacy and Safety of Subjects With Dry Eye Disease
Role: lead
A Methodology Development Environmental Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis
Role: lead
The TRANQUILITY Trial: Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease
Role: lead
The TRANQUILITY 2 Trial: A Phase 3 Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease
Role: lead
A Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Subjects With Plaque Psoriasis
Role: lead
A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Clinical Trial of Reproxalap to Assess the Safety and Efficacy in Subjects With Dry Eye Disease
Role: lead
An Exploratory Crossover Clinical Trial to Compare the Activity of Reproxalap and Lifitegrast in a Dry Eye Disease Chamber
Role: lead
A Clinical Trial to Evaluate the Safety and Efficacy in Subjects With Chronic Cough
Role: lead
A Clinical Trial to Evaluate the Safety and Efficacy of ADX-629 in in Subjects With Elevated Ethanol Levels
Role: lead
A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber
Role: lead
A Clinical Trial to Assess Subjects With Dry Eye Disease.
Role: lead
A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacodynamics for the Treatment of COVID-19.
Role: lead
A Double Masked, Placebo Controlled, Single Center, Randomized Clinical Trial to Assess the Safety and Efficacy of Subjects With Mild Asthma Induced by the Bronchial Allergen Challenge (BAC)
Role: lead